2019. Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S34. DOI:https://doi.org/10.25251/skin.3.supp.34.